Overview

Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Status:
Unknown status

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

Summary

Induction of mixed hemopoietic chimerism in patients using Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in immunosuppression w/CSA & Mycophenolate Mofetil

Phase:

Phase 1

Details

Lead Sponsor:

King Faisal Specialist Hospital & Research Center

Treatments:

Fludarabine
Fludarabine phosphate
Mycophenolate mofetil
Mycophenolic Acid